News

image description Panoptes participates at the BioEurope Spring

12. – 14. March 2018, Amsterdam, The Netherlands. www.ebdgroup.com/bes


image description Panoptes presented at the 14th ISOPT Clinical

The International Symposium on Ocular Pharmacology and Therapeutics March 1-3, 2018, Tel-Aviv, Isreal.


image description Ophthalmology company Panoptes Pharma successfully closed financing round

Press release 5: 11.02.2015
Download Press Release


image description Panoptes will present at Bio Equity Europe

19 – 20 May 2015, Vienna, Austria. More Information


image description Ophthalmology company Panoptes Pharma and Mediolanum announce License Agreement

Press release 4: 09.02.2015 Download Press Release


image description Panoptes participates at the BioEurope

3. – 5. Nov. 2014, Frankfurt, Germany. www.ebdgroup.com/bioeurope


image description Panoptes presents at the OIS, Chicago

16 October 2014, Chicago, USA More Information


image description Ophthalmology company Panoptes Pharma announces in vivo inhibition of choroidal neovascularization by PP-001

Press release 3: 02.06.2014
Download Press Release


image description Panoptes will participate at BioEurope Spring

10.–12. March 2014, Turin, Italy. More Information


image description Panoptes Pharma successfully closed seed-financing round of EUR 1.2 million

Press release 2: 26.09.2013
Download Press Release


image description 4SC Discovery and Panoptes Pharma sign patent transfer agreement for novel compound to treat severe eye diseases

Press release 1: 26.09.2013
Download Press Release


image description Panoptes will present at the Sachs Biotech in Europe Investor Conference

30.Sept. – 1. Oct. 2013, Zurich, Switzerland. More Information


image description Panoptes will present at the Bio-Europe

4. – 6. Nov. 2013, Vienna, Austria. More Information


image description